Mitsubishi Tanabe’s Rupafin Most Promoted Drug in December: Anterio

March 8, 2019
Sales reps at Mitsubishi Tanabe Pharma continued to engage in active calls at GPs for the company’s allergy drug Rupafin (rupatadine) in December to take full advantage of the removal of a 14-day prescription limit on the first day of...read more